Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects dopaminergic neurons in the substantia nigra. Its prevalence is increasing with the aging population, making an in-depth understanding of this disease crucial for providing effective patient care.
PD is characterized by the accumulation of Lewy bodies, composed of alpha-synuclein, in the brain. Genetic and environmental factors contribute to its etiology. Genetic factors include mutations in genes such as SNCA, LRRK2, and PRKN. Environmental factors encompass exposure to pesticides and heavy metals. The loss of dopaminergic neurons leads to motor and non-motor symptoms.
PD typically presents with motor symptoms like bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms including cognitive impairment, depression, sleep disorders, and autonomic dysfunction are often under-recognized but significantly impact patients' quality of life.
PD diagnosis is primarily clinical, based on history and physical examination. Neuroimaging can assist but is not routinely required. Treatment involves pharmacological and non-pharmacological interventions. Levodopa remains the most effective drug, while deep brain stimulation offers an alternative for patients with drug-refractory symptoms.
Healthcare professionals play a critical role in diagnosing PD early, managing its symptoms, and improving the patient's quality of life. Regular monitoring, medication adjustments, and addressing non-motor symptoms are key aspects of care. Multidisciplinary care involving neurologists, physiotherapists, occupational therapists, and psychologists is beneficial.
Enhancing our understanding of Parkinson's disease is essential for its effective management. As healthcare professionals, we must stay abreast of the latest research, understand the complexities of this disease, and strive to provide comprehensive, patient-centered care that improves the quality of life for individuals living with PD.
1.
Is Laughter Good for Blood Glucose Control?
2.
NIH research cuts leave cancer patient facing hard choice
3.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
4.
Ruxolitinib Reduces Acute GVHD in Transplant Patients
5.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
1.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
4.
Biomarkers of Marrow Regenerative Capacity Following Repeated Hematopoietic Stress
5.
Consensus Recommendations for Healthy Hematologic Aging
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation